{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Tumor Treating Fields (TTFields) with maintenance temozolomide (TMZ) and pembrolizumab versus TTFields concomitant with maintenance TMZ and placebo in participants with newly diagnosed glioblastoma.  Keynote D58","item":"https:\/\/www.regionalcancercare.org\/trials\/tumor-treating-fields-ttfields-with-maintenance-temozolomide-tmz-and-pembrolizumab-versus-ttfields-concomitant-with-maintenance-tmz-and-placebo-in-participants-with-newly-diagnosed-glioblastoma\/#breadcrumbitem"}]}